Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19
Clinical trial NCT04486001 · COMPLETED
Trial details
- NCT number
- NCT04486001
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2021-06-09
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.